Skip to main content
Clinical Trials/NL-OMON50705
NL-OMON50705
Recruiting
N/A

TransCatheter Aortic Valve Implantation and Fractional Flow Reserve-Guided Percutaneous Coronary Intervention versus Conventional Surgical Aortic Valve Replacement and Coronary By-Pass Grafts for Treatment of Patients with Coronary MultiVessel Disease and Aortic Valve Stenosis - TCW

Maatschap Cardiologie Zwolle0 sites170 target enrollmentTBD

Overview

Phase
N/A
Intervention
Not specified
Conditions
meervatslijden
Sponsor
Maatschap Cardiologie Zwolle
Enrollment
170
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
Maatschap Cardiologie Zwolle

Eligibility Criteria

Inclusion Criteria

  • 1\) Symptomatic patients aged \>\=70 years with AS fulfilling one of these criteria
  • (AVA \<\=1 cm2; mean gradient \>\=40mmHg; Aortic jet velocity \>4 m/sec; or Velocity
  • index \<\= 0\.25\) feasible for treatment by both trans femoral or subclavian
  • approach TAVI as well as conventional SAVR and where the HT decides that
  • treatment is needed (final decision is left to the HT)
  • 2\) Presence of \>\=2 de novo coronary lesions of \>\=50% diameter stenosis on visual
  • estimation located in any of main epicardial coronary arteries or side branches
  • of a lumen caliber of more than 2 mm or single LAD lesion with more than 20 mm
  • length or involving a bifurcation (complex), feasible for treatment with CABG
  • as well as PCI (HT decision)

Exclusion Criteria

  • 1\) Patients in cardiogenic shock or acute heart failure, requiring inotropic
  • agents during procedure and/or i.v. diuretics \<48 hours before procedure
  • 2\) Left ventricular ejection fraction \<30%
  • 3\) Concomitant presence of other than aortic valve disease requiring
  • intervention
  • 4\) Previous CABG, SAVR, TAVI or thoracotomy for any other reason
  • 5\) Bicuspid or unicuspid aortic valve
  • 6\) Recent myocardial infarction (less than 2 weeks)
  • 7\) Involvement of left main trifurcation (all three branches being larger than
  • 8\) Expected total stent length more 60mm per vessel

Outcomes

Primary Outcomes

Not specified

Similar Trials